Josep Tabernero, M.D., Ph.D.

Josep Tabernero, M.D., Ph.D., is head of medical oncology at Vall d’Hebron Barcelona Hospital, director of Vall d’Hebron Institute of Oncology (VHIO), and head of research innovation for the Catalonian Cancer Centers Network. He specializes in the development of molecular therapies targeting specific oncoproteins and accelerating more effective personalized cancer medicines for patients displaying genetic lesions or pathway dysregulation. He is a member of the European Society for Medical Oncology (ESMO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO).